Older Black and Latino people are significantly more likely to get diagnosed with Alzheimer's Disease than older white people, despite recent medical advancements. Some are trying to close that gap.

Bill Gates visited Indiana University School of Medicine to learn about Alzheimer's research.

Patients and their caregivers are often left to navigate the confusing world of dementia by themselves, but Medicare is launching a new program to change that.

The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.

The Huntington's Disease Society of America's Indiana Chapter will host a one-mile walk in Zionsville on Saturday.

In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.

With Indiana's Election Day approaching Nov. 8 and early voting underway, several listeners are curious about voter rights.

West Lafayette Mayor John Dennis announced Thursday he has been diagnosed with early-onset Alzheimer's disease.

The National Institutes of Health has awarded $217 million to fund research at Indiana University School of Medicine in the current fiscal year. This will fund more research on Alzheimer's and community outreach projects.

An aging population is producing a growing number of Alzheimer’s and dementia diagnoses in the state. These increasing numbers have prompted first year students at the IU School of Medicine in Indianapolis and Fort Wayne to attend training seminars for caring for patients with these diseases.